- Home
- PLX vs AOMR Comparison
PLX vs AOMR Comparison
Compare PLX & AOMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLX | AOMR |
|---|---|---|
| Founded | 1993 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.9M | 210.5M |
| IPO Year | 1996 | 2019 |
Fundamental Metrics
Financial Performance| Metric | PLX | AOMR |
|---|---|---|
| Price | $2.35 | $9.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $12.00 | $11.08 |
| AVG Volume (30 Days) | ★ 686.8K | 90.2K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 14.18% |
| EPS Growth | N/A | ★ 53.85 |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $52,744,000.00 | N/A |
| Revenue This Year | $36.81 | N/A |
| Revenue Next Year | N/A | $1.38 |
| P/E Ratio | $8.74 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.47 | $7.96 |
| 52 Week High | $3.19 | $10.14 |
Technical Indicators
Market Signals| Indicator | PLX | AOMR |
|---|---|---|
| Relative Strength Index (RSI) | 48.40 | 54.19 |
| Support Level | $2.19 | $8.72 |
| Resistance Level | $2.43 | $9.24 |
| Average True Range (ATR) | 0.13 | 0.20 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 28.71 | 70.46 |
Price Performance
Historical ComparisonAbout PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.
About AOMR Angel Oak Mortgage REIT Inc.
Angel Oak Mortgage REIT Inc is a real estate finance company focused on acquiring and investing in first and second lien non-QM loans and other mortgage-related assets in the U.S. mortgage market. Its objective is to generate attractive risk-adjusted returns for its stockholders, through cash distributions and capital appreciation, across interest rate and credit cycles. The company operates in a single operating segment, which is to acquire, invest in, and finance mortgage-related assets.